Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in OCGN — Ocugen, Inc.

CIK 80255 BALTIMORE, MD
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$429,377
+$342,033 QoQ
Shares Held
280,639
+126.8% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 147 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. OCGN ranks #214 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in OCGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $429,377 280,639
2025-03-31 $87,344 123,718
2024-12-31 $91,022 113,072
2024-09-30 $233,973 235,860
2024-06-30 $416,671 268,820
2024-03-31 $306,844 187,100
2023-12-31 $107,582 187,100
2023-09-30 $37,640 94,100
2023-06-30 $16,995 31,300
2023-03-31 $143,562 168,303
2022-12-31 $212,851 163,732
2022-09-30 $243,543 136,822
2022-06-30 $281,529 124,022
2022-03-31 $429,798 130,242
2021-12-31 $580,730 127,633
2021-09-30 $761,489 106,057
2021-06-30 $323,263 40,257
2021-03-31 $83,517 12,300